COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE"

Transcription

1 COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE MINUTES OF THE COVENTRY AND WARWICKSHIRE AREA PRESCRIBING COMMITTEE HELD ON FRIDAY 17 th MARCH 2017 AT PM IN THE CLINICAL SCIENCES BUILDING (CSB) AT UHC&W NHS TRUST PRESENT: - Richard Lambert South Warwickshire GP (RL) Vice-chair Altaz Dhanani Coventry & Rugby CCG (AD) Interim secretary Joe Booker Coventry LMC (JB) Jane Smith Coventry GP (JS) Claire Keane Coventry GP (CK) Rita Sanghera Arden & GEM CSU representing Warwickshire North and South Warwickshire CCG (RS) Ruth David Arden & GEM CSU representing Warwickshire North CCG (RD) Nigel Johnson Warwickshire North CCG (NJ) Kim Panting South Warwickshire GP (KP) Bernhard Usselmann South Warwickshire NHS Trust (BU) Ashwin Hindocha Coventry LPC (Ahi) Satyan Kotecha Warwickshire LPC (SK) Franco Cappuccio University Hospitals Coventry & Warwickshire NHS Trust (FC) Mark Easter - University Hospitals Coventry & Warwickshire NHS Trust (ME) Cath Sansby - University Hospitals Coventry & Warwickshire NHS Trust (CS) Paul Mills George Eliot Hospital NHS Trust (PM) Loay David George Eliot Hospital NHS Trust (LD) David Tait Coventry & Warwickshire Partnership Trust (DT) Ian Bayman Lay Member (IB) Terry Spicer Lay Member (TS) IN ATTENDANCE: Anita Hunjan (AH), Susan Dhesi (SD) 1. APOLOGIES Simon Fletcher, Priti Ved, Bev Bazant-Hegemark, Genette Edmunds, Martin Phillips, Paula Harris, Portia Chikwanha 2. MINUTES OF THE LAST MEETING The minutes of the last meeting held on 27th January 2017 were agreed with the exception of some grammatical changes on pages 2/3 matters arising 7.4 items and paragraphs 5.1.2, 8.1.1, which were to be amended prior to the publication of the minutes. 1

2 2.2 - Action log RL went through the list of outstanding actions that still required the committee s response. He suggested adding a date completion by to the action log. 3. MATTERS ARISING DT briefly updated the committee about the ADHD commissioning model that Coventry and Warwickshire Partnership Trust were implementing to increase the capacity and to have all ADHD patients as shared care (SC). He confirmed that it looks as if the CCGs will not provide the extra funds and subsequently this will impact on transition patients, as there are no provisions available to continue treatment in primary care unless they have a severe mental health condition. NJ advised that the LMC are keen to withdraw from the shared care protocol, they feel there is not appropriate funding available for services in primary care. RL felt that this discussion was more of a commission matter rather than an Area Prescribing Committee (APC) issue. DT insisted that it was an APC issue as it impacts on safety and quality. He felt that it would be beneficial if the committee were to agree on a consensus on the reclassification of the shared care agreement (SCA) to classify all ADHD age groups as shared care. Section 3 Decisions 3A completed declaration interest form RH/SDh/PH/PC 3B David Weston ( LMC Lead letter) to RL & SF NJ 4. APC Development 4.1 RMOC update AD updated the committee on his attendance at last month's development workshop. Key plan outcomes were:- RMOC inauguration first meeting will be held at the end of April 2017 Subsequent meetings will be held on a monthly basis One RMOC split into 4 regional areas: The North, The South, The Midlands& The East and London all acting as one whole body No recruitment of members has taken place yet, delegates were asked various questions regarding who should be represented No confirmed decisions on how it will all pan out Above the RMOCs will sit a Medicines Optimisation Priority panel (MOPs) this group will devise and prioritise what the RMOCs should be discussing AD stated that he will send the committee a link to the RMOC proposal and the feedback/discussion taken place at the workshops. His view was that APCs will still be crucial to the local health economy. The APCs will not be forced to abide by the RMOCs decision locally which defeats the purpose of the new remit 2

3 NJ asked if there were any discussions around the of Drug and Therapeutic Committees (DTCs), AD said that DTCs were not mentioned, he added that the RMOC fundamental principle is to reduce the workload of APCs and DTCs AD pointed out that there were lots of reservations from delegates about Pharmaceutical Industry representations 4.2 APC Website AD notified the committee that SD is currently working with ArdenGem GP fusion IT to reformat the current website layout to make navigation to documents more accessible and user friendly. The launch date is 1 st April 2017 and he asked the committee to provide feedback. Section 4 Decisions 4A Send RMOC workshop link to the committee AD 5. Drug Positioning Statements Opicapone A DPS was brought to the committee for consideration as adjunctive therapy to preparations of levodopa/dopa decarboxylase inhibitors (DDCI) in adult patients with Parkinson s disease (PD) and end-of-dose motor fluctuations who cannot be stabilised on those combinations; AH summarised the contents of the draft DPS; stating that this was a once a day preparation, EMA review evidence was shown to be non-inferior to entacapone. The safety intolerability appeared to be good Committee viewed item 7.5 Parkinson disease algorithm at this point CS described the draft Parkinson disease algorithm which was devised by consultants at University Hospital Coventry and Warwickshire NHS Trust (UHCW), placing opicapone as second-line to entacapone and noting that consultants do not use tolcapone JB commented that tolcapone is always an issue in primary care RL asked if there is a plan to have a combined preparation IB commented on the contra-indication paragraph and suggested naming the MAO-A and MAO-B class of inhibitors The committee agreed that the verdict status should read as specialist initiated (SI) Safinaminde A DPS was brought to the committee for consideration for the treatment of adult patients with idiopathic Parkinson s disease (PD) as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients AH briefly summarised the contents of the draft DPS; a once daily dosage that can be increased, it is more expensive compared with other drugs. There is no data on the long- 3

4 term use and no dietary restrictions; it is also placed in the algorithm as an option where other drugs are not tolerated BU questioned the contraindication with pethidine, he said they use it often in their trust RD thought the algorithm was excellent guidance; she suggested that these drugs should be added to the netformulary, her recommendation were 3, 4, 5 drugs to be placed as preferred line, 7, 8, 9 drugs to be placed as second line and the bottom line drugs can be placed as third line RL thought that duodopa was a funding request drug RD questioned whether further drug clarification was needed especially around the COMT inhibitor The committee agreed that the verdict status should read as SI and the revised algorithm should be brought back to the next meeting after seeking approval from the neurologists Relvar Ellipta A decision review request discussed at the last meeting was brought back to the committee for reconsideration along with a revised DPS; AH briefly summarised that there is no significant change from the previous DPS, the main addition is changing the BTS guideline where it positions relvar 92/22 as low to medium dose and the 184/22 strength positioned as high dose. The BTS guidelines suggest that high dose patients should be referred to secondary care. Ellipta device is a once daily dose which may be more beneficial to some patients JB recalled that the committee previously had two reasons for rejection; the colour of the device and concerns around vilanterol IB read out a summary of the observation study PM pointed out that the LABA/LAMA had already been approved The committee agreed the verdict status should read as recommended use in primary care, to amend the asthma guidelines and update the net formulary Paliperidone - A DPS along with a draft SIDC from CWPT was brought to the committee for consideration for the treatment of schizophrenia in adult patients who are clinically stable on 1- monthly paliperidone palmitate injectable product DT summarised the contents of the draft DPS; introduction of a 3-monthly depot injection. CWPT propose that their patients should be stabilised for at least 12 months, specialists should complete the back page (internal use only) and approve those steps. The advantage of this product is that patients are only injected 4 times a year and receive a more sustained cover. He added that the verdict statement reflects what happens in primary care for GP prescribing. 4

5 5.4.2 NJ queried ECG assessments and thought that CWPT should be carrying out these assessments The committee agreed for verdict status to read as SI and also approved the SIDC. The four DPSs would be reformatted into the correct template and then published. Section 5 Decisions 5A Write opicapone DPS verdict & send out for virtual ratification, format document and then publish on both websites ALL 5B Write safinamide DPS verdict & send out for virtual ratification, format document and then publish on both websites ALL 5C Re-write relvar (asthma) DPS verdict, format document and then republish on both websites AH/SD 5D Amend Asthma guidelines and republish AH/SD 5E Write to specialist regarding relvar decision review outcome AD 5F Format paliperidone 3-monthly depot injection DPS and publish to both websites AD/SD 5G Publish paliperidone 3-monthly checklist to both websites AD/SD 6. Specialist Drugs List SDL Amendments Five proposed amendments from CRCCG were brought to the committee for consideration to change the renal immunosuppressant drugs SC classification; AD recommended to the committee that Azathioprine, Tacrolimus (oral), Ciclosporin (oral), Sirolimus, and Mycophenolate be changed to specialist only (SO). National guidance recommends that all transplant drugs be repatriated to secondary care and that UHCW homecare system will supply and prescribe from the trust JB requested that this be highlighted on the APC website; he said that these drugs are used currently for different indications and classifications and that junior doctors find this confusing. RD confirmed that this will be highlighted on the netformulary website BU asked about the renal drugs process in South Warwickshire; RL informed that there is a mix of out of area patients needing prescribing The committee agreed to publish the proposed amendments SDL Amendment An amendment request from UHCW Breast Surgeons was brought to the committee for consideration to change aromatase inhibitors to SI; CS briefly informed that the breast surgeons do not feel that this should be SC 5

6 RD and JS both stressed that the monitoring of discharge patients is crucial and specialists need to alert GPs CS said that she will feedback the committee comments The committee agreed to this amendment. Section 6 Decisions 6A Publish the agreed SDL amendments RD/SD 7. Guidelines/Resource Documents Local Blacklist amendment One proposed amendment from ArdenGEM CSU was brought to the committee for consideration; RD asked the committee to consider the inclusion of coconut oil, an OTC product which is not listed in the BNF The committee agreed to this proposal Local Blacklist amendment One proposed amendment clarification from CWPT Podiatry was brought to the committee for consideration; DT highlighted that the request is to make an exception to dermatonics once heel balm (25% urea ointment) as it can be prescribed for the management of foot problems in high risk patients when recommended by a specialist from podiatry and dermatology services IB said there is no evidence of support for 25%; however evidence is available for 10% product. He thought that 25% flexitol is much cheaper JB asked if the product was available over the counter (OTC) The committee rejected this proposal, but agreed to a blacklist amendment for 10% urea product being submitted to the next meeting Infant Formula A revised guidance along with a draft quick reference guide from SWFT and UHCW dietitians was brought to the committee for consideration; AD read out a summary of the changes to the revised guidance; Similac Alimentum added as a first line treatment; Althera added as a second line treatment options for CMPA and Alfamino added for completeness as a third line option from dietitians CK thought the document was very useful; however the overall guidance seemed bit lengthy 6

7 SK commented on the following:- 1. Page 2 do not table pre-thickened formula should stipulate names and say they are OTC products. 2. Queried the quantities supplied and suggested prescribers should add these as repeat dispensing on a quarterly basis which will reduce waste in community pharmacies 3. Suggested that the cost should be included for all the products The committee agreed that the revised guidance be amended with the committee comments, sent out for virtual ratification and then republished along with the quick reference guide Parkinson s disease algorithm this item was discussed along with items 5.1 and Antimuscarincs A revised guidance discussed at the December 2016 meeting was brought back to the committee for reconsideration; CS mentioned that the Urologists wanted to simplify the pathway; remove the extended release preparations, remove solifenacin which is too expensive and move mirabegron to third line RD noted that tolterodine MR is a once a day formulation and suggested that it remained on the algorithm PM asked if the APC should focus on a more effective treatment pathway rather than having a separate pathway for women. CS confirmed that NICE have already separated their guidance for men and women IB stated that solifenacin should remain as an add-on therapy to mirabegron for some patients Committee briefly debated the solifenacin and mirabegron treatment therapy The committee agreed to amend guidelines and republish Chronic Constipation A UHCW pathway that had been discussed at previous meetings with disagreement around some of the newer agents that did not follow the NICE guidance, was brought to the committee for reconsideration; CS briefed the background to previous meeting discussions; the consultant view is that GPs are in an ideal position to prescribe chronic constipation drugs as they see patients frequently. Consultants request that all these drugs are reclassified for primary care prescribing JB felt that most GPs do not have the experience in using the new agents and that the existing drugs are well tolerated by the majority of patients BU added that the consultants would often do further investigations first before prescribing these drugs to patients, he questioned how this would work in primary care RL queried what the definition of adequate responsibility was 7

8 GP members preferred the secondary care referral to be done before the switch to newer agents The committee agreed for this pathway to be amended with the committee's comments and then published as guidance Fast-acting insulin - A joint formulary application submitted by Diabetologists and Endocrinologists from all 3 trusts was considered requesting inclusion of the new generation injection; AD reported that the new formulation has a therapeutic advantage over existing treatment IB commented that the reason for the Fiasp request is pure speculation, he stated that the key trials have not been published but there is a full EMA report. There is no data on important outcomes. IB read out the evidence report and noted with respect to safety, there was a difference in the pattern of hypoglycaemic episodes with a significantly higher rate of hypoglycaemia within the first 2 hours after the meal for Fiasp compared to Novorapid. However, the overall rate and severity of events was comparable between treatments RD queried the no excess cost compared to standard therapy SK thought the benefit is that the device is much better and the advantage is that the insulin can be give during the mealtime The committee agreed for this application to be brought back with more evidence to support its use and give better cost comparison against existing insulins. Section 7 Decisions 7A Publish the agreed local blacklist amendments RD/SD 7B Feedback dermatonics once heel balm 25% decision outcome to CWPT Podiatry Clinical Lead DT 7C Bring blacklist addition form for Dermatonics once heel balm 10% DT 7D Amend infant formula guidance and republish AD/SD 7E Publish infant formula quick reference guide on APC website AD/SD 7F Bring back revised Parkinson disease algorithm to the next meeting, add item to May agenda CS/SD 7G Amend antimuscarinic pathway and republish to APC website, amend drugs on netformulary CS/RD/SD 7H Amend chronic constipation pathway with committee comments publish on APC website CS/RD/SD 7I Write to specialist requesting some more evidence on fast acting insulin, bring application back item to the next meeting AD/SD 8

9 8. Shared Care Agreements Metolazone - A UHCW proposed SCA was brought to the committee for consideration for the treatment of fluid overload in patients with heart failure; CS briefly stated that metolazone is now an unlicensed drug, and she had a request to devise a share care agreement RD confirmed that the drug is expensive and is a special item. She said that she had concerns around the patient safety aspect in primary care Committee members did not recall a previous meeting discussion, a brief debate took place around the prescribing concerns in primary care AD asked who had requested the SCA; he thought that a drug classification needed to be defined as GPs are quite often asked to prescribe metolazone The committee agreed for the specialist classification to be placed as specialist only (SO) until the cost price decreases. Section 8 Decisions 8A Change metolazone status on netformulary RD/SD 9. AOB Hypertension guidance - FC mentioned that the current guidance on the APC website dated January 2013 is out of date. He suggested that it required an overall update of the therapies and to have a simplified pathway. FC noted that the issue is that NICE have already started to review the national guidance alongside the British Hypertension Society (BHS) and this will be published in FC confirmed that in his hypertension clinic a number of concerns have arisen relating to secondary and primary care. At present they are inundated with referrals which breach the 18 weeks rule. FS felt strongly that he was unable to provide an efficient service FC asked for the committee's view on whether they thought it was better to redraft the existing document now or to wait for the national guidance to be published AD commented that it would make sense to reformat the document now and any national guidance amendment could then be added at a later date The committee agreed to the proposal of reformatting the guidance and to bring the revised document to the meeting for approval. 9

10 9.2 - NJ reported on the new secondary care contract effective from 1 st April 2017, in which secondary care are to issue the first prescription and send a letter of advice to GP practices if they wish them to take over the prescribing. He acknowledged that the LMC will take action if the process is not adhered too ME answered that he understood that there might be a contractual issue, however, there is an existing agreement between the hospital trusts and CCGs. It is a national decision and is outside the remit of this committee RL suggested confirming clarification of the local agreement under matters arising at the next meeting SK informed that there is a National Urgent Medicine Service (NUMS) for community pharmacies that has been commissioned nationally. It is for those patients who have run out of their medicines; patients can contact NHS 111 who will contact a community pharmacy direct to supply emergency medication. SK wondered what the local medication supply guidance was for Coventry and Warwickshire. Community pharmacies have discretion of up to 30 days of supply. He stated that this system is not a repeat dispensing service, currently the default is 28 days supply unless otherwise stated in the local guidance AD asked how this service fits in with the emergency supply that community pharmacies can already provide SK replied that it is part of the contractual change for community pharmacies, the figures state that 200,000 patient telephone calls a year are made to NHS 111 service AD urged those members who submit meeting attendance invoices, that they should be completed and sent to the office within 2 weeks after each meeting otherwise invoices may not be processed. Section 9 Decisions 9A Devise revised hypertension guidance and bring back to meeting FC/SD 10. Date of next meeting The date and time of the next meeting is Friday 19 th May 2017 at pm until 3pm. 10

COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE

COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE MINUTES OF THE COVENTRY AND WARWICKSHIRE AREA PRESCRIBING COMMITTEE HELD ON FRIDAY 15 TH SEPTEMBER 2017 AT 12.30 PM IN THE CLINICAL SCIENCES BUILDING

More information

COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE

COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE MINUTES OF THE COVENTRY AND WARWICKSHIRE AREA PRESCRIBING COMMITTEE HELD ON FRIDAY 16 TH MARCH 2018 AT 12.30 PM IN THE CLINICAL SCIENCES BUILDING (CSB)

More information

COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE

COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE MINUTES OF THE COVENTRY AND WARWICKSHIRE AREA PRESCRIBING COMMITTEE HELD ON 19 TH JANUARY 2018 AT 12.30 PM IN THE CLINICAL SCIENCES BUILDING (CSB) AT

More information

COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE

COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE COVENTRY & WARWICKSHIRE AREA PRESCRIBING COMMITTEE MINUTES OF THE COVENTRY AND WARWICKSHIRE AREA PRESCRIBING COMMITTEE HELD ON 17 TH NOVEMBER 2017 AT 12.30 PM IN THE CLINICAL SCIENCES BUILDING (CSB) AT

More information

South East London Area Prescribing Committee (APC) 9 October at Lower Marsh. Final minutes

South East London Area Prescribing Committee (APC) 9 October at Lower Marsh. Final minutes South East London Area Prescribing Committee (APC) 9 October at Lower Marsh Final minutes 1. Welcome, Introductions and Apologies received. 2. Conflicts of Interest declarations The Chair requested any

More information

Oxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 6

Oxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 6 Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 3 January 2017 Paper No: 6 Title of Presentation Primary Care Prescribing report Is this paper

More information

Hertfordshire Medicines Management Committee (HMMC)

Hertfordshire Medicines Management Committee (HMMC) Hertfordshire Medicines Management Committee (HMMC) TERMS OF REFERENCE 1. CONTEXT The following publications have been considered for the development of the HMMC Terms of Reference: The NHS Constitution

More information

NHS community pharmacy advanced services Briefing for GP practices

NHS community pharmacy advanced services Briefing for GP practices NHS community pharmacy advanced services Briefing for GP practices August 2013 This document has been developed jointly by NHS Employers, the Pharmaceutical Services Negotiating Committee (PSNC) and the

More information

SOMERSET PRESCRIBING FORUM

SOMERSET PRESCRIBING FORUM SOMERSET PRESCRIBING FORUM Minutes of the meeting held at Wynford House, Yeovil, on Wednesday 13 March 2013 Present Position Initials Dr Clare Barlow Chair, Drug & Therapeutics Committee, Taunton & Somerset

More information

3. Minutes, action log and attendance list of Last Meeting and Matters Arising. The minutes of the January meeting were accepted as accurate.

3. Minutes, action log and attendance list of Last Meeting and Matters Arising. The minutes of the January meeting were accepted as accurate. South East London Area Prescribing Committee (SELAPC) 30 March 2017 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests,

More information

North Central London Medicines Optimisation Network. Terms of Reference. North Central London Medicines Optimisation Network 1 of 8

North Central London Medicines Optimisation Network. Terms of Reference. North Central London Medicines Optimisation Network 1 of 8 North Central London Medicines Optimisation Network Medicines Optimisation Committee Terms of Reference North Central London Medicines Optimisation Network 1 of 8 Document control Date Version Amendments

More information

Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services

Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing

More information

Prescribing. -Clinical Commissioning Groups - CCG. -Prescribing teams. -epact data. -APC & Joint Formulary. -Traffic lights and shared care protocols

Prescribing. -Clinical Commissioning Groups - CCG. -Prescribing teams. -epact data. -APC & Joint Formulary. -Traffic lights and shared care protocols Prescribing -Clinical Commissioning Groups - CCG -Prescribing teams -epact data -APC & Joint Formulary -Traffic lights and shared care protocols -Medication review -Unlicensed meds / Specials Primary Care

More information

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Switch protocol: Brands to generic equivalent

Switch protocol: Brands to generic equivalent Switch protocol: Brands to generic equivalent Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team hosted by HaRD CCG for

More information

Minutes 18 July 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager

Minutes 18 July 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager Quality and Clinical Governance Committee Date Chair Minutes 18 July @ 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager Members Present Gareth

More information

Interface Pharmacist Network Specialist Medicines Shared Care Guidelines

Interface Pharmacist Network Specialist Medicines Shared Care Guidelines Interface Pharmacist Network Specialist Medicines Shared Care Guidelines Guidance on the development & maintenance of shared care guidelines for amber listed medicines June 2012 Contents Section 1 Introduction

More information

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse

More information

DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from 28 th June NHS Doncaster CCG RDaSH FT Doncaster LPC

DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from 28 th June NHS Doncaster CCG RDaSH FT Doncaster LPC Present: DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from 28 th June 2018 NHS Doncaster CCG RDaSH FT Doncaster LPC Dr David Crichton ( APC Chair) Mr Alex Molyneux - Head of Medicines Management

More information

NHS BARNSLEY. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House.

NHS BARNSLEY. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House. PRESENT: Dr M Ghani (Chair) Medical Director Barnsley CCG (Designate) Dr

More information

Venue: Salford St James House Present: Name Designation Organisation CCG members

Venue: Salford St James House Present: Name Designation Organisation CCG members GREATER MANCHESTER MEDICINES MANAGEMENT GROUP Minutes Date: Thursday 16 th February 2017 Time: 1pm 3pm Venue: Salford St James House Present: Name Designation Organisation CCG members Dr Helen Burgess

More information

South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide

South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide 1. Introduction 1.1 This policy has been developed by the South East London Clinical Commissioning

More information

Coastal West Sussex Interface Prescribing Policy

Coastal West Sussex Interface Prescribing Policy Coastal West Sussex Interface Prescribing Policy Agreement between Commissioners: Coastal West Sussex CCG And Providers: Western Sussex NHS Foundation Trust (WSfT) Sussex Community NHS Trust (SCT) Sussex

More information

South East London Area Prescribing Committee (APC) 13 June 2013 Final approved minutes

South East London Area Prescribing Committee (APC) 13 June 2013 Final approved minutes South East London Area Prescribing Committee (APC) 13 June 2013 Final approved minutes 1. Welcome and Introductions and Apologies received. 2. Conflicts of Interest declarations HS clarified the understanding

More information

NHS PRESCRIBING RECOMMENDED DURING OR AFTER AN EPISODE OF PRIVATE CARE

NHS PRESCRIBING RECOMMENDED DURING OR AFTER AN EPISODE OF PRIVATE CARE East Surrey CCG Guildford & Waverley CCG North West Surrey CCG Surrey Downs CCG Surrey Heath CCG Crawley CCG Horsham & Mid Sussex CCG NHS PRESCRIBING RECOMMENDED DURING OR AFTER AN EPISODE OF PRIVATE CARE

More information

DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August NHS Doncaster CCG RDaSH FT Doncaster LPC

DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August NHS Doncaster CCG RDaSH FT Doncaster LPC Present: DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August 2015 NHS Doncaster CCG RDaSH FT Doncaster LPC Dr Rumit Shah ( APC Chair) Mr Mark Randerson- Head of Medicines

More information

South East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions

South East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions South East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests,

More information

3. Minutes, action log and attendance list of Last Meeting and Matters Arising. The minutes of the March meeting were accepted as accurate.

3. Minutes, action log and attendance list of Last Meeting and Matters Arising. The minutes of the March meeting were accepted as accurate. South East London Area Prescribing Committee (APC) 23 June 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests, either

More information

Minutes of the Meeting of the Area Drug and Therapeutics Committee held at 14:30 on Friday 10 April 2015, in Meeting Room 8, Waverley Gate.

Minutes of the Meeting of the Area Drug and Therapeutics Committee held at 14:30 on Friday 10 April 2015, in Meeting Room 8, Waverley Gate. LOTHIAN NHS BOARD AREA DRUG AND THERAPEUTICS COMMITTEE Minutes of the Meeting of the Area Drug and Therapeutics Committee held at 14:30 on Friday 10 April 2015, in Meeting Room 8, Waverley Gate. Present:

More information

Hospital Pharmacy Transformation Plan

Hospital Pharmacy Transformation Plan Hospital Pharmacy Transformation Plan Introduction In June 2014, Lord Carter of Coles was appointed to the position of Chair of a new NHS Procurement & Efficiency Board to direct the NHS Procurement &

More information

Medicines Management Guidance

Medicines Management Guidance Medicines Management Guidance Status Final Version 1.0 Author Jon Boyd Version date 05/12/2016 Agreed by the following North West London CCGs: Central London West London Hammersmith and Fulham Hounslow

More information

Is Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better?

Is Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better? Is Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better? Vanessa Burgess, Assistant Director, Medicines & LTCs, NHS Lambeth Clinical Commissioning Group;

More information

Reducing medicines waste in Care Settings.

Reducing medicines waste in Care Settings. Reducing medicines waste in Care Settings. Good practice Guidance Recommendations for care home staff, prescribers and pharmacists working with care homes. This good practice guidance has been developed

More information

Reconciliation of Medicines on Admission to Hospital

Reconciliation of Medicines on Admission to Hospital Reconciliation of Medicines on Admission to Hospital Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For

More information

With these corrections made, it was agreed that the Minutes be approved as a correct record.

With these corrections made, it was agreed that the Minutes be approved as a correct record. Agenda item 14 CCG Operational Leadership Team 18 July 2013, 8.30 11.30am Board Room, Trust HQ, St Martin s Hospital In Attendance: Simon Douglass (Chair) (SD) Hester McLain (For Item 10) Tracey Cox (Chair)

More information

Healthwatch Coventry Steering Group pre-meeting At: am on 28 March 2017 Held At: Queens Road Baptist Church Centre. Minutes

Healthwatch Coventry Steering Group pre-meeting At: am on 28 March 2017 Held At: Queens Road Baptist Church Centre. Minutes Healthwatch Coventry Steering Group pre-meeting At: 10.00 am on 28 March 2017 Held At: Queens Road Baptist Church Centre Minutes Attendees: John Mason (Chair), Carol Fawkes, David Spurgeon, Derek Rawle

More information

Guidance on the supply of Monitored Dosage Systems (MDS) by Community Pharmacies

Guidance on the supply of Monitored Dosage Systems (MDS) by Community Pharmacies Guidance on the supply of Monitored Dosage Systems (MDS) by Community Pharmacies Document Description Document Type Service Application Guidelines General Practitioners, Dudley Community Services (DCS)

More information

Minutes 8 th March 2018, 1pm-3pm HMR CCG, Nye Bevan House, Rochdale

Minutes 8 th March 2018, 1pm-3pm HMR CCG, Nye Bevan House, Rochdale 1. General Business Minutes 8 th March 2018, 1pm-3pm HMR CCG, Nye Bevan House, Rochdale 1.1) pologies received: s below ttendee Representing Mar May July Sept Nov Faduma kbar (F) Senior medicines Optimisation

More information

NHS ENGLAND BOARD PAPER

NHS ENGLAND BOARD PAPER NHS ENGLAND BOARD PAPER Paper: PB.04.07.2018/05 Title: Developing the NHS long term plan: primary care reform Lead National Director: Ian Dodge, National Director, Strategy and Innovation Purpose of Paper:

More information

The PCT Guide to Applying the 10 High Impact Changes

The PCT Guide to Applying the 10 High Impact Changes The PCT Guide to Applying the 10 High Impact Changes This Guide has been produced by the NHS Modernisation Agency. For further information on the Agency or the 10 High Impact Changes please visit www.modern.nhs.uk

More information

Minutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting pm, Wednesday 9 September 2013 Room 407, 1 Lower Marsh

Minutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting pm, Wednesday 9 September 2013 Room 407, 1 Lower Marsh Minutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting 2. 00 pm, Wednesday 9 September 2013 Room 407, 1 Lower Marsh Present: Dr Di Aitken Catherine Otty Sian Howell Sadru Kheraj

More information

DRAFT MINUTES OF THE ONE HUNDRED AND THIRTY EIGHTH MEETING MEETING HELD ON THURSDAY 18 TH JULY 2013 IN THE POSTGRADUATE MEDICAL CENTRE ROOM 2, NDDH

DRAFT MINUTES OF THE ONE HUNDRED AND THIRTY EIGHTH MEETING MEETING HELD ON THURSDAY 18 TH JULY 2013 IN THE POSTGRADUATE MEDICAL CENTRE ROOM 2, NDDH DRUG AND THERAPEUTICS COMMITTEE DRAFT MINUTES OF THE ONE HUNDRED AND THIRTY EIGHTH MEETING MEETING HELD ON THURSDAY 18 TH JULY 2013 IN THE STGRADUATE MEDICAL CENTRE ROOM 2, NDDH Present: xxxxxx xxxxxx

More information

Prescribing and Medicines Optimisation Strategy

Prescribing and Medicines Optimisation Strategy Prescribing and Medicines Optimisation Strategy - for consultation Dr Robin Jackson Executive Lead Dr Kamlesh Sidhu GP Prescribing Lead The Challenge Medicines the most common health intervention delivered

More information

Medicines Reconciliation: Standard Operating Procedure

Medicines Reconciliation: Standard Operating Procedure Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE HEALTH AND SOCIAL CARE DIRECTORATE QUALITY STANDARD CONSULTATION SUMMARY REPORT

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE HEALTH AND SOCIAL CARE DIRECTORATE QUALITY STANDARD CONSULTATION SUMMARY REPORT NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE HEALTH AND SOCIAL CARE DIRECTORATE QUALITY STANDARD CONSULTATION SUMMARY REPORT 1 standard title Nocturnal enuresis Date of Standards Advisory Committee

More information

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Royal Pharmaceutical Society response The Royal Pharmaceutical Society (RPS) is the professional

More information

LEICESTER, LEICESTERSHIRE AND RUTLAND CCGs COMMISSIONING COLLABORATIVE BOARD

LEICESTER, LEICESTERSHIRE AND RUTLAND CCGs COMMISSIONING COLLABORATIVE BOARD LEICESTER, LEICESTERSHIRE AND RUTLAND CCGs COMMISSIONING COLLABORATIVE BOARD Minutes of the Public Commissioning Collaborative Board held on Thursday 19 April 2018 at 1:00pm in the Conference Room, 8 th

More information

This SLA covers an enhanced service for care homes for older people and not any other care category of home.

This SLA covers an enhanced service for care homes for older people and not any other care category of home. Care Homes for Older People Service Level Agreement 2016-2019 All practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This service

More information

Medicines Management Service Components

Medicines Management Service Components Medicines Management Service Components 1. Enabling Medicines Decision Making - facilitating processes across the health economy that inform CCG strategic planning, support best use of resources and enable

More information

Commissioning Policy

Commissioning Policy Commissioning Policy Consultant to Consultant Referrals Version 6.0 December 2017 Name of Responsible Board / Committee for Ratification: North Staffordshire CCG Stoke on Trent CCG Date Issued: November

More information

Process for the Managed Entry of New Drugs to the Hywel Dda Health Board Formulary (October 2010)

Process for the Managed Entry of New Drugs to the Hywel Dda Health Board Formulary (October 2010) Process for the Managed Entry of New Drugs to the Hywel Dda Health Board Formulary (October 2010) Consultant or GP completes formulary application form. Interface Pharmacist (IP) receives formulary application

More information

AREA PRESCRIBING COMMITTEE MEETING Birmingham, Sandwell, Solihull and environs Minutes of the meeting held on

AREA PRESCRIBING COMMITTEE MEETING Birmingham, Sandwell, Solihull and environs Minutes of the meeting held on AREA PRESCRIBING COMMITTEE MEETING Birmingham, Sandwell, Solihull and environs Minutes of the meeting held on Venue Birmingham Research Park Vincent Drive, Birmingham, B15 2SQ PRESENT: Dr Paul Dudley Prof

More information

A meeting of Bromley CCG Primary Care Commissioning Committee 22 March 2018

A meeting of Bromley CCG Primary Care Commissioning Committee 22 March 2018 A meeting of Bromley CCG Primary Care Commissioning Committee 22 March 2018 ENCLOSURE 7 PROPOSAL FOR ENHANCED MEDICAL SUPPORT TO BROMLEY CARE HOMES SUMMARY: Bromley CCG gained agreement at the CCG Clinical

More information

Executive Committee Monday 4 th March :30-15:30 TO24, Warehouse k

Executive Committee Monday 4 th March :30-15:30 TO24, Warehouse k Executive Committee Monday 4 th March 2013 13:30-15:30 TO24, Warehouse k Present Steve Gilvin(Chair) Dr Hardip Nandra Dr Zuhair Zarifa Jane Lindo Bob Arora Dr Ashwin Shah Dr Prakash Chandra (14:00-15:30)

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes 1.1 Short title Medicines

More information

NHS DORSET CLINICAL COMMISSIONING GROUP (CCG) PRIMARY CARE REFERENCE GROUP (PCRG) 26 SEPTEMBER 2018 NOTES

NHS DORSET CLINICAL COMMISSIONING GROUP (CCG) PRIMARY CARE REFERENCE GROUP (PCRG) 26 SEPTEMBER 2018 NOTES NHS DORSET CLINICAL COMMISSIONING GROUP (CCG) PRIMARY CARE REFERENCE GROUP (PCRG) 26 SEPTEMBER 2018 NOTES A meeting of the Primary Care Reference Group of NHS Dorset Clinical Commissioning Group was held

More information

Medication Requests for Patients in Care Homes

Medication Requests for Patients in Care Homes 11 th January 2013 To: All GPs and Community Pharmacists Nursing and Residential Homes Directorate of Integrated Care 12-22 Linenhall Street Belfast BT2 8BS Tel : 028 90553782 Fax : 028 90553622 Web Site:

More information

Minutes of the Lancashire Medicines Management Group Meeting Held on Thursday 8 th March 2018 at Preston Business Centre

Minutes of the Lancashire Medicines Management Group Meeting Held on Thursday 8 th March 2018 at Preston Business Centre Minutes of the Meeting Held on Thursday at Preston Business Centre PRESENT: Dr Tony Naughton (TN) Chair of LMMG Lancashire CCG Network Dr Sonia Ramdour (SR) Chief Pharmacist Lancashire Care NHS Foundation

More information

Regional Medicines Optimisation Committees

Regional Medicines Optimisation Committees Regional Medicines Optimisation Committees Operating Model First Edition, April 2017 NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and Information Nursing Trans.

More information

Repeat Dispensing Services Resource Pack

Repeat Dispensing Services Resource Pack Repeat Dispensing Services Resource Pack This pack has been produced to support Local Health Boards in establishing Repeat Dispensing Services, an Essential Service under the New Pharmacy Contract. NHS

More information

Principles of Shared Care Protocols

Principles of Shared Care Protocols Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the

More information

Clinical Commissioning Group

Clinical Commissioning Group Clinical Commissioning Group Title of Meeting: Time: NHS Rotherham Medicines Management Committee Meeting 9.00am 11.00am Date: Wednesday 8 th October 2017 Venue: Reference: Chair: Cedar Room G.02 Oak House

More information

NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12. Date of Meeting: 23 rd March 2018 TITLE OF REPORT:

NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12. Date of Meeting: 23 rd March 2018 TITLE OF REPORT: NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12 Date of Meeting: 23 rd March 2018 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)

More information

DAPSONE for dermatology indications

DAPSONE for dermatology indications PAN MERSEY AREA PRESCRIBING COMMITTEE SHARED CARE FRAMEWORK APC BOARD DATE: 25 APR 2018 PENDING CCG APPROVAL Pan Mersey Area Prescribing Committee DAPSONE for dermatology indications 1. Background Dapsone

More information

1 SERVICE LEVEL AGREEMENT

1 SERVICE LEVEL AGREEMENT 1 SERVICE LEVEL AGREEMENT This Service Level Agreement (SLA) stipulates the contractual terms applied to the relationship between: NHS Commissioning Board (The Commissioner, NHS England) and The Community

More information

NHS ENGLAND CALL TO ACTION: IMPROVING HEALTH AND PATIENT CARE THROUGH COMMUNITY PHARMACY

NHS ENGLAND CALL TO ACTION: IMPROVING HEALTH AND PATIENT CARE THROUGH COMMUNITY PHARMACY Delivering local pharmacy solutions in Sunderland Chair David Carter Secretary Louise Lydon Chair Umesh Patel Secretary Jim Smith NHS ENGLAND CALL TO ACTION: IMPROVING HEALTH AND PATIENT CARE THROUGH COMMUNITY

More information

WAO reviewed primary care prescribing In November 2012 and developed a report which was published in December 2013.

WAO reviewed primary care prescribing In November 2012 and developed a report which was published in December 2013. Wales Audit Office Primary Care Prescribing Review Update Against Action Plan WAO reviewed primary care prescribing In November 2012 and developed a report which was published in December 2013. It is recognised

More information

Three steps to success

Three steps to success Inpatient care for people with diabetes at Russells Hall Hospital (The Dudley Group NHS Foundation Trust) Three steps to success The ThinkGlucose team at Russells Hall Hospital developed a three-stage

More information

Code of Conduct. Service: Primary Care Mental Health Alliance (incorporating EPC Depot Contract) Programme Board: Mental Health Programme Board

Code of Conduct. Service: Primary Care Mental Health Alliance (incorporating EPC Depot Contract) Programme Board: Mental Health Programme Board Code of Conduct Service: Primary Care Mental Health Alliance (incorporating EPC Depot Contract) Programme Board: Mental Health Programme Board Question Part A - Developing the service specification Please

More information

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion. THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines

More information

South East London Area Prescribing Committee (SEL APC) 25 January 2018 at Lower Marsh Final minutes 1. Welcome, and Introductions

South East London Area Prescribing Committee (SEL APC) 25 January 2018 at Lower Marsh Final minutes 1. Welcome, and Introductions South East London Area Prescribing Committee (SEL APC) 25 January 2018 at Lower Marsh Final minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests,

More information

NON-MEDICAL PRESCRIBING POLICY

NON-MEDICAL PRESCRIBING POLICY NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August

More information

Provision of Near-Patient Testing Service. Service Level Agreement Background. 2. Financial Details

Provision of Near-Patient Testing Service. Service Level Agreement Background. 2. Financial Details Provision of Near-Patient Testing Service Service Level Agreement 2016-2019 Contents: 1. Financial Details 2. Service Aims 3. Criteria 4. Ongoing Measurement & Evaluation 5. Accreditation 1. Background

More information

Pharmacy Medicine Use Review What s it all about?

Pharmacy Medicine Use Review What s it all about? Pharmacy Medicine Use Review What s it all about? 1. What is it? 1.1 Medicine use Review has been introduced under the Advanced Services tier of the New Pharmacy Contract in England & Wales. The aim of

More information

MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY

MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt

More information

Northern, Eastern & Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group

Northern, Eastern & Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Notes of: Meeting of the South and West Devon Formulary Interface Group Wednesday, 11 th January 2017: 2:00pm 4.30 pm The Watermark, Erme Court, Leonards Road, Ivybridge PL21 0SZ Present: Andrew Gunatilleke

More information

Minutes for Primary Care Commissioning Committee Monday 20 February 2017, 9.30am Meeting Room 3, Beccles House, Beccles (Meeting held in public)

Minutes for Primary Care Commissioning Committee Monday 20 February 2017, 9.30am Meeting Room 3, Beccles House, Beccles (Meeting held in public) Minutes for Primary Care Commissioning Committee Monday 20 February 2017, 9.30am Meeting Room 3, Beccles House, Beccles (Meeting held in public) Present Name: Position: Organisation: Cedric Burton (CB)

More information

Community Nurse Prescribing (V100) Portfolio of Evidence

Community Nurse Prescribing (V100) Portfolio of Evidence ` School of Health and Human Sciences Community Nurse Prescribing (V100) Portfolio of Evidence Start date: September 2016 Student Name: Student Number:. Practice Mentor:.. Personal Tutor:... Submission

More information

Clinical pharmacists in general practice links with community pharmacy

Clinical pharmacists in general practice links with community pharmacy Introduction Pharmacists employed in the GP clinical pharmacist NHS England programme are encouraged to complete online activity recording. One of the activities records how they are working with community.

More information

CLINICAL PHARMACY SERVICE STANDARDS

CLINICAL PHARMACY SERVICE STANDARDS CLINICAL PHARMACY SERVICE STANDARDS (Incorporating MEDICINES OPTIMIZATION) Version 3 October 2017 Lead authors: Jed Hewitt, Chief Pharmacist - Governance & Professional Practice Ray Lyon, Chief Pharmacist

More information

HERTFORDSHIRE LOCAL PHARMACEUTICAL COMMITTEE

HERTFORDSHIRE LOCAL PHARMACEUTICAL COMMITTEE Unit 8 Weltech Centre, Ridgeway, Welwyn Garden City, Herts, AL7 2AA Tel: 01707 390095 Fax: 01707 390124 Email: info@hertslpc.org.uk www.hertslpc.org.uk OPEN MEETING MINUTES Wednesday 25 January 2017 Ramada

More information

Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9

Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 Meeting of Bristol Clinical Commissioning Group To be held on Tuesday, 2 July 2013 commencing at 1.30 pm in the BAWA Centre Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 1 Purpose

More information

How NICE clinical guidelines are developed

How NICE clinical guidelines are developed Issue date: January 2009 How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS Fourth edition : an overview for stakeholders, the public and the NHS Fourth edition

More information

NHS PCA (P) (2015) 17 ANNEX B. Specials Frequently Asked Questions for Community Pharmacy. Pre-authorisation:

NHS PCA (P) (2015) 17 ANNEX B. Specials Frequently Asked Questions for Community Pharmacy. Pre-authorisation: ANNEX B Specials Frequently Asked Questions for Community Pharmacy Pre-authorisation: Q: When do I need to seek authorisation? A: You need to seek authorisation for all Specials manufactured medicines

More information

Working with you to make Highland the healthy place to be

Working with you to make Highland the healthy place to be HIGHLAND NHS BOARD Assynt House Beechwood Park Inverness IV2 3HG Tel: 01463 717123 Fax: 01463 235189 Textphone users can contact us via Typetalk: Tel 0800 959598 www.nhshighland.scot.nhs.uk Highland NHS

More information

ANTI-COAGULATION MONITORING

ANTI-COAGULATION MONITORING ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This

More information

Unlicensed Medicines Policy

Unlicensed Medicines Policy Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention

More information

PRESCRIBING SUPPORT TECHNICIAN:

PRESCRIBING SUPPORT TECHNICIAN: PRESCRIBING SUPPORT TEAM AUDIT: CARDURA XL (Updated Sept 09) DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Cardura XL is a once daily, extended release preparation of doxazosin

More information

GOVERNING BODY MEETING Wednesday 27 March 2013 Agenda Item 2.5

GOVERNING BODY MEETING Wednesday 27 March 2013 Agenda Item 2.5 GOVERNING BODY MEETING Wednesday 27 March 2013 Agenda Item 2.5 Name of Paper / Report Lead Author Contributors Governing Body Sponsor Service Level Agreement between NHS Vale Royal CCG NHS Eastern Cheshire

More information

NHS DORSET CLINICAL COMMISSIONING GROUP JOINT PRIMARY CARE COMMISSIONING COMMITTEE. 3 February 2016 PART ONE PUBLIC MINUTES

NHS DORSET CLINICAL COMMISSIONING GROUP JOINT PRIMARY CARE COMMISSIONING COMMITTEE. 3 February 2016 PART ONE PUBLIC MINUTES NHS DORSET CLINICAL COMMISSIONING GROUP JOINT PRIMARY CARE COMMISSIONING COMMITTEE 3 February 2016 PART ONE PUBLIC MINUTES Part 1 of the Joint Primary Care Commissioning Committee of NHS Dorset Clinical

More information

A Collaboration between Portsmouth City, Southampton City and Hampshire Primary Care Trusts (PCTs)

A Collaboration between Portsmouth City, Southampton City and Hampshire Primary Care Trusts (PCTs) Enclosure 7 A Collaboration between Portsmouth City, Southampton City and Hampshire Primary Care Trusts (PCTs) The Provision of NHS Orthodontic Care across Hampshire Questions and Answers Portsmouth City,

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Quality standards Process guide December 2014 Quality standards process guide Page 1 of 44 About this guide This guide

More information

Free of charge (FOC) medicines schemes

Free of charge (FOC) medicines schemes Free of charge (FOC) medicines schemes Advice ratified by the Regional Medicines Optimisation Committee for adoption as local policy July 2018 Version 1.0 DOCUMENT CONTROL Document location Copies of this

More information

The Alberta Pharmacists Practice Model, Implications for Hospital Pharmacists. October 2014

The Alberta Pharmacists Practice Model, Implications for Hospital Pharmacists. October 2014 The Alberta Pharmacists Practice Model, Implications for Hospital Pharmacists October 2014 Disclosure I have no real or potential conflict to disclose Learning Objectives Understand the principles in which

More information

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company

More information

Shared Care Agreements for Medicines

Shared Care Agreements for Medicines Shared Care Agreements for Medicines Author: Scott Garden, Chief Pharmacist, Acute Services Version: 1.0 Authorised by: NHS Fife Area Drug and Therapeutics Committee Date of Authorisation: Review Date:

More information

An investigation of breastfeeding support in Coventry November 2012

An investigation of breastfeeding support in Coventry November 2012 An investigation of breastfeeding support in Coventry November 2012 Responses received 1 LINk s Recommendations 1. Commissioners ensure adequate provision of antenatal support for women in pregnancy regarding

More information

EAST LANCASHIRE HEALTH ECONOMY MEDICINES MANAGEMENT BOARD IN PHARMACY SEMINAR ROOM, PHARMACY DEPARTMENT, ROYAL BLACKBURN HOSPITAL

EAST LANCASHIRE HEALTH ECONOMY MEDICINES MANAGEMENT BOARD IN PHARMACY SEMINAR ROOM, PHARMACY DEPARTMENT, ROYAL BLACKBURN HOSPITAL EAST LANCASHIRE HEALTH ECONOMY MEDICINES MANAGEMENT BOARD MINUTES OF THE MEETING HELD ON WEDNESDAY 19 TH DECEMBER 2018 AT 12.30pm IN PHARMACY SEMINAR ROOM, PHARMACY DEPARTMENT, ROYAL BLACKBURN HOSPITAL

More information

Clinical Commissioning Group

Clinical Commissioning Group Clinical Commissioning Group Title of Meeting: NHSR Medicines Management Committee Meeting Time: 9.00am to 11.00am Date: Wednesday 26 October 2016 Venue: Cedar Room, Oak House Reference: AG/JAA Chairman:

More information

Setting up the NOAC Service & Taking it to Primary Care

Setting up the NOAC Service & Taking it to Primary Care Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015 Buckinghamshire Health Care NHS Trust Quiz 1. What is the most serious side

More information